Medtronic MDT Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Cardiovascular | $3.8B+13.8% | $3.46B+13.8% | $3.44B+10.8% | $3.29B+9.2% | $3.34B+6.6% | |
| Diabetes | $838M+15.1% | $796M+14.7% | $757M+10.3% | $721M+11.4% | $728M+10.5% | |
| Medical Surgical | $2.39B+8.0% | $2.17B+4.9% | $2.17B+2.0% | $2.08B+4.4% | $2.21B+0.6% | |
| Neuroscience | $2.75B+5.0% | $2.56B+4.1% | $2.56B+4.5% | $2.42B+4.3% | $2.62B+2.9% | |
| Other Operating Segments | $33.75M-1.5% | $33.75M-1.5% | $33.75M-1.5% | $33.75M-1.5% | $34.25M-38.0% | |
| Net Sales by Geography | ||||||
| Ireland | $39M+30.0% | $36M+28.6% | $35M+20.7% | $33M+10.0% | $30M+11.1% | |
| Rest of world | $4.9B+12.6% | $4.49B+11.4% | $4.41B+8.4% | $4.32B+13.6% | $4.35B+3.1% | |
| United States | $4.87B+7.1% | $4.49B+6.0% | $4.52B+4.9% | $4.22B+3.5% | $4.55B+4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Medtronic break its business down?
- Medtronic (MDT) reports net sales by business across 6 parts — Cardiovascular, Diabetes, Medical Surgical, Neuroscience and Other operating segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Medtronic's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Medtronic's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
